HelixPep is a research-focused company providing peptides and laboratory products for scientific research and experimental applications.
We understand that research depends on consistency. That's why every batch we sell is independently lab-tested for identity and purity, with a Certificate of Analysis available for each one.
From individual researchers to professional laboratories, HelixPep is built to provide a straightforward research supply experience — without compromising on the details that matter.
Welcome to Our Company
Survodutide (also known as BI 456906) is a glucagon receptor/glucagon-like peptide-1 receptor (GCGR/GLP-1R) dual agonist, jointly developed by Boehringer Ingelheim and Zealand Pharma, and is intended to treat metabolic diseases such as obesity and non-alcoholic steatohepatitis.
Survodutide is a drug with an innovative mechanism of action and is expected to become a potential option for the treatment of obesity and metabolic-related diseases. Multiple clinical studies are underway to evaluate its safety and efficacy.
Quality First Safety Guaranteed

Send a Message
We'd love to hear from you if you have any questions!